Alexandria, VA (PRWEB) July 31, 2014
On October 10, at the Palmer House Hilton hotel in Chicago, Illinois, the Mesothelioma Applied Research Foundation, in collaboration with the University of Chicago Medicine, will host a one-day regional mesothelioma conference geared to patients and family members, covering a variety of topics related to mesothelioma and presented by local and regional experts.
Some of the covered topics will include imaging, genetics, first-line therapies, surgery, chemotherapy, radiation therapy, novel treatments, stem cells, immunotherapy, and resources available to mesothelioma patients and their families.
Samuel Armato, PhD, The University of Chicago Medicine
Christopher Straus, MD, The University of Chicago Medicine
Jane Churpek, MD, The University of Chicago Medicine
Funmi Olopade, MD, The University of Chicago Medicine
Lee Krug, MD, Memorial Sloan Kettering Cancer Center
Wickii Vigneswaran, MD, The University of Chicago Medicine
David Sugarbaker, MD, Baylor College of Medicine
Jason Foster, MD, University of Nebraska Medical Center
Brian Loggie, MD, Creighton University Medical Center
Kiran Turaga, MD, Medical College of Wisconsin
Richard Alexander, MD, University of Maryland Medical Center
Renuka Malik, MD, The University of Chicago Medicine
Ravi Salgia, MD, The University of Chicago Medicine
Hedy Kindler, MD, The University of Chicago Medicine
Faris Farassati, MD, University of Kansas Medical Center
Tobias Peikert, MD, Mayo Clinic
Mary Hesdorffer, APRN, Mesothelioma Applied Research Foundation
Melinda Kotzian, Mesothelioma Applied Research Foundation
More information and registration is available at http://www.curemeso.org/chicago.
The Meso Foundation is also the host of an annual symposium, taking place in March of every year in the Washington, DC area, and another regional conference in Philadelphia in September.
Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. Medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the Navy or working in shipyards.
ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION
The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund peer-reviewed mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer reviewed scientific research to establish effective treatments for mesothelioma and, ultimately, a cure for this extremely aggressive cancer. To date, the Foundation has awarded over $8.7 million to research. More information is available at http://www.curemeso.org.